S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Israel is quiet on next steps against Iran -- and on which partners helped shoot down missiles
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Israel is quiet on next steps against Iran -- and on which partners helped shoot down missiles
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Israel is quiet on next steps against Iran -- and on which partners helped shoot down missiles
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota
S&P 500   5,123.41
DOW   37,983.24
QQQ   438.27
Divisive? Not for moviegoers. ‘Civil War’ declares victory at box office.
Israel is quiet on next steps against Iran -- and on which partners helped shoot down missiles
Can homeless people be fined for sleeping outside? A rural Oregon city asks the US Supreme Court
Germany's Scholz arrives in China on a visit marked by trade tensions and Ukraine conflict
India's Modi vows to boost social spending, make country into a manufacturing hub ahead of election
Olympic track uniforms spark online debate about who designed them and why they're so skimpy
Native American-led nonprofit says it bought 40 acres in the Black Hills of South Dakota

BriaCell Therapeutics (BCTXW) News Today

$1.09
+0.03 (+2.83%)
(As of 04/12/2024 ET)
SourceHeadline
finance.yahoo.com logoGet Rich Quick With These 3 Penny Stocks to Buy Now
finance.yahoo.com - February 20 at 9:51 AM
finanznachrichten.de logoBriaCell Therapeutics Corp.: BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case
finanznachrichten.de - February 7 at 10:32 AM
finance.yahoo.com logoBreaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing
finance.yahoo.com - February 6 at 9:16 AM
theglobeandmail.com logoBriaCell Therapeutics: Bottom 25 Performing Stocks Year-to-Date on TSX (BCT)
theglobeandmail.com - January 6 at 1:21 PM
finance.yahoo.com logoBriaCell Images Confirm Robust Anti-Tumor Activity in Patient with “Eye-Bulging” Metastatic Breast Cancer
finance.yahoo.com - January 4 at 9:08 AM
finance.yahoo.com logoBriaCell 2023 SABCS Posters Confirm Activation of Cancer-Fighting Immune Cells and Identify Potential Predictors of Clinical Benefit
finance.yahoo.com - December 6 at 9:47 AM
finanznachrichten.de logoBriaCell Therapeutics Corp.: BriaCell Records New Responder with Remarkable Improvement of "Eye-Bulging" Metastatic Tumor
finanznachrichten.de - November 30 at 9:40 AM
finance.yahoo.com logoBriaCell Records New Responder with Remarkable Improvement of “Eye-Bulging” Metastatic Tumor
finance.yahoo.com - November 30 at 9:40 AM
finance.yahoo.com logoBriaCell Announces Presentations at the 2023 Society for the Immunotherapy of Cancer (SITC) and San Antonio Breast Cancer (SABC) Conferences
finance.yahoo.com - October 18 at 12:37 PM
finance.yahoo.com logoBriaCell Partners with New York Cancer & Blood Specialists (NYCBS) for Pivotal Phase 3 Study of Bria-IMT™ in Advanced Breast Cancer
finance.yahoo.com - October 4 at 9:26 AM
finance.yahoo.com logoBriaCell Receives Court Approval for the Share Arrangement Spinning Out BriaPro Therapeutics (SpinCo) to Existing Shareholders
finance.yahoo.com - August 25 at 3:43 PM
finance.yahoo.com logoBriaCell Enters Definitive Arrangement Agreement for the Spin Out of BriaPro Therapeutics Corp.
finance.yahoo.com - May 25 at 9:41 AM
finance.yahoo.com logoBriaCell Presents Positive Data Demonstrating Survival and Clinical Benefits in Advanced Metastatic Breast Cancer at the 2023 AACR
finance.yahoo.com - April 17 at 8:39 AM
bizjournals.com logoBriaCell intends to launch a spinoff to accelerate its drug development activities
bizjournals.com - April 3 at 1:58 PM
finance.yahoo.com logoBriaCell to Present Clinical and Survival Data in Advanced Metastatic Breast Cancer at the 2023 AACR Annual Meeting
finance.yahoo.com - March 15 at 9:34 AM
finanznachrichten.de logoBriaCell Therapeutics Corp.: BriaCell to Investigate Alleged Illegal Trading of Public Securities
finanznachrichten.de - January 23 at 2:41 PM
finance.yahoo.com logoBriaCell Announces New Patent Issuance, Bria-OTS™ IND Timing Guidance, and Additional Clinical Sites to Boost Enrolment
finance.yahoo.com - January 10 at 10:26 AM
finance.yahoo.com logoBriaCell Announces Positive Clinical and Quality of Life Data in Advanced Metastatic Breast Cancer at 2022 San Antonio Breast Cancer Symposium®
finance.yahoo.com - December 8 at 2:45 PM
finance.yahoo.com logoBriaCell Announces Successful Completion of Phase I Portion of Clinical Study in Advanced Breast Cancer; Randomized Phase II Efficacy Evaluation Progressing
finance.yahoo.com - October 21 at 9:15 AM
finance.yahoo.com logoBriaCell Secures License for a Promising Novel Anti-Cancer Agent
finance.yahoo.com - August 4 at 9:27 AM
finance.yahoo.com logoBriaCell Enters Research Agreement to Identify Novel Targets for Cancer Treatment
finance.yahoo.com - June 29 at 9:27 AM
Get BriaCell Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCTXW and its competitors with MarketBeat's FREE daily newsletter.

What is Medicare Supplement Insurance? (Ad)

Original Medicare helps covers a lot of hospital and medical services, but it still leaves some out- of- pocket medical costs to recipients. Make sure your family’s nest egg is protected from unpredictable medical expenses. Consider applying for a Medicare Supplement Insurance Plan that travels with you.

Learn More Here

BCTXW Media Mentions By Week

BCTXW Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BCTXW
News Sentiment

1.43

0.65

Average
Medical
News Sentiment

BCTXW News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BCTXW Articles
This Week

2

0

BCTXW Articles
Average Week

Get BriaCell Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCTXW and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:BCTXW) was last updated on 4/14/2024 by MarketBeat.com Staff

From Our Partners